Drug-induced hyperglycemia.

[1]  F. Goebel,et al.  Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus , 1999, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

[2]  S. Jacob,et al.  Differential effect of chronic treatment with two beta‐blocking agents on insulin sensitivity: the carvedilol‐metoprolol study , 1996, Journal of hypertension.

[3]  S. Marder,et al.  Novel antipsychotics and new onset diabetes , 1998, Biological Psychiatry.

[4]  H. Mehnert,et al.  Effects of beta-blocking agents on insulin secretion and glucose disposal. , 1990, Hormone and metabolic research. Supplement series.

[5]  J. Bilezikian,et al.  HIV disease and the endocrine system. , 1992, The New England journal of medicine.

[6]  G. Keusch,et al.  Infection and diabetes: the case for glucose control. , 1982, The American journal of medicine.

[7]  R. Marfella,et al.  Metabolic and Cardiovascular Effects of Carvedilol and Atenolol in Non-Insulin-Dependent Diabetes Mellitus and Hypertension , 1997, Annals of Internal Medicine.

[8]  H. Schmidt,et al.  Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. , 1999, AIDS.

[9]  L. Rames,et al.  Diabetic ketoacidosis associated with clozapine treatment. , 1994, The American journal of psychiatry.

[10]  T. Stern,et al.  New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment. , 1999, Psychosomatics.

[11]  J. J. Henning,et al.  Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000 , 1998, HIV clinical trials.

[12]  O. Spigset,et al.  Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications. , 1998, The Journal of clinical psychiatry.

[13]  T. Erbas,et al.  Ketoacidosis as a side‐effect of clozapine: a case report , 1996, Acta psychiatrica Scandinavica.

[14]  R. Conley,et al.  Adverse events related to olanzapine. , 2000, The Journal of clinical psychiatry.

[15]  S. Yusuf,et al.  The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. , 1999, Diabetes care.

[16]  E. Jaggers,et al.  New-onset diabetes mellitus associated with the initiation of quetiapine treatment. , 1999, The Journal of clinical psychiatry.

[17]  D. Andersen,et al.  Prevention of the Glucose Intolerance of Thiazide Diuretics by Maintenance of Body Potassium , 1983, Diabetes.

[18]  M. Crismon,et al.  Olanzapine-Induced Glucose Dysregulation , 2000, The Annals of pharmacotherapy.

[19]  F. Goebel,et al.  Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV‐1‐infected patients , 1998, AIDS.

[20]  J. Avorn,et al.  Antihypertensive Drug Therapy and the Initiation of Treatment for Diabetes Mellitus , 1993, Annals of Internal Medicine.

[21]  H. Gin,et al.  Diabetes as a result of atypical anti‐psychotic drugs – a report of three cases , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[22]  J. Chan,et al.  Drug-Induced Disorders of Glucose Metabolism , 1996, Drug safety.

[23]  M. Schambelan,et al.  Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection. , 2000 .

[24]  R. Sherer,et al.  Management of the adverse effects of antiretroviral therapy and medication adherence. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  P. Croarkin,et al.  Diabetic ketoacidosis associated with risperidone treatment? , 2000, Psychosomatics.

[26]  J. McMurry,et al.  Wound healing with diabetes mellitus. Better glucose control for better wound healing in diabetes. , 1984, The Surgical clinics of North America.

[27]  J. Touraine,et al.  Effects of metformin on insulin resistance and central adiposity in patients receiving effective protease inhibitor therapy. , 1999, AIDS.

[28]  G. Tse,et al.  New-onset diabetes mellitus associated with quetiapine. , 2000, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[29]  Kilby Jm,et al.  Severe hyperglycemia in an HIV clinic: preexisting versus drug-associated diabetes mellitus. , 1998 .

[30]  F. Nieto,et al.  Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus , 2000 .

[31]  J. Currier.  How to manage metabolic complications of HIV therapy: what to do while we wait for answers. , 2000, The AIDS reader.

[32]  R. Hudak,et al.  Hyperglycemia and olanzapine. , 1999, The American journal of psychiatry.

[33]  J. Bagdade,et al.  Impaired Granulocyte Adherence: A Reversible Defect in Host Defense in Patients with Poorly Controlled Diabetes , 1978, Diabetes.

[34]  W. Kerner,et al.  Perioperative management of the diabetic patient. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[35]  P. Masand,et al.  Insulin-resistant hyperglycemia induced by clozapine. , 2000, Psychosomatics.

[36]  D. Goff,et al.  Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study. , 2000, The American journal of psychiatry.

[37]  P. Wilson,et al.  Is hyperglycemia associated with cardiovascular disease? The Framingham Study. , 1991, American heart journal.

[38]  P. Decina,et al.  Diabetes mellitus in schizophrenic patients. , 1996, Comprehensive psychiatry.

[39]  J. Lindenmayer,et al.  Olanzapine-induced ketoacidosis with diabetes mellitus. , 1999, The American journal of psychiatry.

[40]  T. Hedner,et al.  Diabetes mellitus in treated hypertension: incidence, predictive factors and the impact of non-selective beta-blockers and thiazide diuretics during 15 years treatment of middle-aged hypertensive men in the Primary Prevention Trial Göteborg, Sweden. , 1994, Journal of human hypertension.

[41]  T. Erbas,et al.  The effect of clozapine on glucose metabolism. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[42]  Beverley Balkau,et al.  High Blood Glucose Concentration Is a Risk Factor for Mortality in Middle-Aged Nondiabetic Men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study , 1998, Diabetes Care.

[43]  A. Peiris,et al.  Drug-Induced Disorders of Glucose Tolerance , 1993, Annals of Internal Medicine.

[44]  P. Sax,et al.  Metformin in the treatment of HIV lipodystrophy syndrome: A randomized controlled trial. , 2000, JAMA.

[45]  G. Jurjus,et al.  Clozapine and associated diabetes mellitus. , 1997, The Journal of clinical psychiatry.

[46]  Peters Ga,et al.  DIABETIC KETOACIDOSIS FROM CLOZAPINE AND LITHIUM COTREATMENT , 1996 .

[47]  W. White,et al.  Management of patients with hypertension and diabetes mellitus: advances in the evidence for intensive treatment. , 2000, The American journal of medicine.

[48]  P. S. Shelton,et al.  Hyperglycemia associated with olanzapine. , 1998, The Journal of clinical psychiatry.